E-mail contact for the Memphis Lung Research Program website: Gail Spake
Last Updated: 6/18/01
Disclaimer, Internet Technology Policy, Network Publishing Guidelines, UT Home Page
The University of Tennessee is an EEO/AA/Title VI/Title IX/Section 504/ADA/ADEA institution.

Memphis Lung Research Program
University of Tennnessee Health Science Center
Coleman College of Medicine
956 Court Avenue, Room H316
Memphis, TN 38163

Our Mission/ Vision Statement

Program Accomplishments

Who We Are

History of the Memphis Lung Research Program

Our investigators have been studying ARDS since 1989 at the University of Tennessee Health Science Center at Memphis, Tennessee. Our early investigations concentrated on monitoring the natural history of ARDS, during which time the important observation was made that steroid rescue therapy appeared to be helpful in resolving ARDS. This was an important discovery because other investigators had disputed that steroids worked to treat ARDS. We found that how long a patient had ARDS at the start of treatment, the dosage of steroids given, and the length of steroid administration are all important factors in determining treatment response. During the next phase of our research we completed a controlled study, which required use of steroids and controls (placebo/no steroids), in order to prove to the scientific community that our observations were correct. We found that survival and length of time on a breathing machine for those with unresolved ARDS (defined as having ARDS for at least 7 days) who were treated with steroids was much better when compared with those who did not receive steroids. These results were published in the July 1998 issue of the Journal of the American Medical Association. This was a very important study and has changed treatment for many ARDS patients.